ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019
August 28, 2019New data from Aslan’s study of Varlitinib in patients with advanced or metastatic biliary tract cancer will be presented at upcoming 2019 Chinese Society of Clinical Oncology (CSCO) annual meeting; a largest clinical trial conducted to date on biliary tra
Pharma Sources Insight January 2025
